BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36942661)

  • 1. EXT418, a novel long-acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice.
    Kerr HL; Krumm K; Lee II; Anderson B; Christiani A; Strait L; Breckheimer BA; Irwin B; Jiang AS; Rybachok A; Chen A; Caeiro L; Dacek E; Hall DB; Kostyla CH; Hales LM; Soliman TM; Garcia JM
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1337-1348. PubMed ID: 36942661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone secretagogue receptor-1a mediates ghrelin's effects on attenuating tumour-induced loss of muscle strength but not muscle mass.
    Liu H; Zang P; Lee II; Anderson B; Christiani A; Strait-Bodey L; Breckheimer BA; Storie M; Tewnion A; Krumm K; Li T; Irwin B; Garcia JM
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1280-1295. PubMed ID: 34264027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors.
    Beaudry AG; Law ML; Gilley-Connor KR; Buley H; Dungan CM; Nascimento CMC; Vichaya EG; Wiggs MP
    Am J Physiol Regul Integr Comp Physiol; 2024 Mar; 326(3):R254-R265. PubMed ID: 38252513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of S-pindolol in mouse pancreatic and lung cancer cachexia models.
    Springer J; Jové Q; de Lima Junior EA; Ladrón NÁ; López-Soriano FJ; Busquets S; Argiles JM; Marks DL
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1244-1248. PubMed ID: 37130578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity worsens mitochondrial quality control and does not protect against skeletal muscle wasting in murine cancer cachexia.
    Cardaci TD; VanderVeen BN; Bullard BM; McDonald SJ; Unger CA; Enos RT; Fan D; Velázquez KT; Frizzell N; Spangenburg EE; Murphy EA
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):124-137. PubMed ID: 38062911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
    Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice.
    Tsubouchi H; Yanagi S; Miura A; Matsumoto N; Kangawa K; Nakazato M
    Eur J Pharmacol; 2014 Nov; 743():1-10. PubMed ID: 25257464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
    Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement by eicosanoids in cancer cachexia induced by LLC-IL6 transplantation.
    Ohira T; Nishio K; Ohe Y; Arioka H; Nishio M; Funayama Y; Ogasawara H; Fukuda M; Yazawa K; Kato H; Saijo N
    J Cancer Res Clin Oncol; 1996; 122(12):711-5. PubMed ID: 8954167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.
    Yoshimura M; Shiomi Y; Ohira Y; Takei M; Tanaka T
    Eur J Pharmacol; 2017 Sep; 811():30-37. PubMed ID: 28529141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel orthotopic mouse model replicates human lung cancer cachexia.
    van de Worp WRPH; Theys J; González AS; van der Heyden B; Verhaegen F; Hauser D; Caiment F; Smeets HJM; Schols AMWJ; van Helvoort A; Langen RCJ
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1410-1423. PubMed ID: 37025071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia.
    Weber BZC; Agca S; Domaniku A; Bilgic SN; Arabaci DH; Kir S
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1582-1594. PubMed ID: 35373517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R-ketorolac ameliorates cancer-associated cachexia and prolongs survival of tumour-bearing mice.
    Chrysostomou SE; Eder S; Pototschnig I; Mayer AL; Derler M; Mussbacher M; Schauer S; Zhang D; Yan D; Liu G; Hoefler G; Weichhart T; Vesely PW; Zhang L; Schweiger M
    J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):562-574. PubMed ID: 38302863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting FFA1 and FFA4 receptors in cancer-induced cachexia.
    Freitas RDS; Muradás TC; Dagnino APA; Rost FL; Costa KM; Venturin GT; Greggio S; da Costa JC; Campos MM
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E877-E892. PubMed ID: 32893672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice.
    Massart IS; Kouakou AN; Pelet N; Lause P; Schakman O; Loumaye A; Abou-Samra M; Deldicque L; Bindels LB; Brichard SM; Thissen JP
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):919-933. PubMed ID: 38572511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rikkunshito ameliorates cachexia associated with bleomycin-induced lung fibrosis in mice by stimulating ghrelin secretion.
    Tsubouchi H; Yanagi S; Miura A; Mogami S; Yamada C; Iizuka S; Hattori T; Nakazato M
    Nutr Res; 2014 Oct; 34(10):876-85. PubMed ID: 25270999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice.
    Garcia JM; Scherer T; Chen JA; Guillory B; Nassif A; Papusha V; Smiechowska J; Asnicar M; Buettner C; Smith RG
    Endocrinology; 2013 Sep; 154(9):3118-29. PubMed ID: 23832960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ghrelin on body composition and muscle function in a long-term rodent model of critical illness.
    Hill NE; Murphy KG; Saeed S; Phadke R; Chambers D; Wilson DR; Brett SJ; Singer M
    PLoS One; 2017; 12(8):e0182659. PubMed ID: 28796827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.
    Puppa MJ; Gao S; Narsale AA; Carson JA
    FASEB J; 2014 Feb; 28(2):998-1009. PubMed ID: 24145720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.